Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank87
3Y CAGR+35.4%
5Y CAGR+8.6%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+35.4%/yr
Quarterly compound
5Y CAGR
+8.6%/yr
Recent acceleration
Percentile
P87
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q1 2023 | 58.18% |
| Q4 2022 | 46.08% |
| Q3 2022 | 14.94% |
| Q2 2022 | -80.56% |
| Q1 2022 | 61.84% |
| Q4 2021 | -11.36% |
| Q3 2021 | 24.91% |
| Q2 2021 | -30.83% |
| Q1 2021 | 46.43% |
| Q4 2020 | -58.93% |
| Q3 2020 | -8.44% |
| Q2 2020 | -18.52% |
| Q1 2020 | 23.42% |
| Q4 2019 | -32.71% |
| Q3 2019 | 11.46% |
| Q2 2019 | 9.58% |
| Q1 2019 | 11.13% |
| Q4 2018 | -46.70% |
| Q3 2018 | 15.41% |
| Q2 2018 | -35.81% |
| Q1 2018 | 38.51% |
| Q4 2017 | -165.59% |
| Q3 2017 | 15.12% |
| Q2 2017 | 14.55% |
| Q1 2017 | -23.51% |
| Q4 2016 | -7.96% |
| Q3 2016 | 27.56% |
| Q2 2016 | -251.44% |
| Q1 2016 | -112.05% |
| Q4 2015 | 81.57% |
| Q3 2015 | -47176.47% |
| Q2 2015 | 99.84% |
| Q1 2015 | -1227.27% |
| Q4 2014 | 60.46% |
| Q3 2014 | -195.63% |
| Q2 2014 | 94.28% |
| Q1 2014 | -275.02% |
| Q4 2013 | 51.00% |
| Q3 2013 | -26.09% |
| Q2 2013 | -119.04% |